CEO of Novo Nordisk, Lars Rebien Sørensen, takes the top spot on the annual list of the 100 best performing CEOs in the world.
A new agreement sees a nationwide rollout of telemedicine for COPD patients in Denmark.
Danish researchers have made a groundbreaking discovery using a malaria protein for treatment of cancer. The new research shows that the treatment works on almost all types of cancer.
Danish researchers from DTU Systems Biology have developed a new innovative technology called the TumorTracer, which diagnoses cancer in two days.
Denmark is the highest ranking European country on this year's Global Creativity Index.
A new prehospital solution, which enables better patient treatment, has been installed in all Danish ambulances.
Hospitals in the Capital Region of Denmark and Region Zealand will soon implement the new technology, Medical Device Integration Platform (MDI), which enables better treatment and improves patient safety.
A new app called XHALE from the Danish Cancer Society helps young people quit smoking by providing tips and advice from Danish celebrities.
The U.S. Food and Drug Administration (FDA) approves the insulin preparations Tresiba and Ryzodeg by Danish pharmaceutical company, Novo Nordisk.
Danish researchers are currently working on a computer program with the aim to identify women at high risk of developing breast cancer.